Full-Time

Area Innovation Manager

Endoscopy

Posted on 9/26/2025

Deadline 10/10/25
Medtronic

Medtronic

10,001+ employees

Medical device maker advancing therapies

Compensation Overview

$115.5k/yr

+ Sales Incentive Plan

Seattle, WA, USA + 3 more

More locations: Boise, ID, USA | Sacramento, CA, USA | Portland, OR, USA

Remote

Candidates must reside within the territory and drive to multiple accounts throughout the region.

Category
Sales & Account Management (2)
,
Required Skills
Sales
Business Strategy
Data Analysis
Requirements
  • Bachelors degree required
  • Minimum of 3 years of relevant experience and complete knowledge of company products and services
Responsibilities
  • Achieve monthly, quarterly, and annual sales quotas by driving product adoption through the delivery of clinical and economic value of Medtronic AI platforms
  • Expertise in artificial intelligence trends including but limited to market positioning of GI Genius and macroeconomic factors that influence decision making in AI in healthcare.
  • Thorough understanding of the current and future AI competitive landscape, including non-AI technology designed to improve patient outcomes. Ability to position Medtronic AI platforms as the market leader.
  • Have a well-documented record of accomplishment of successfully targeting, converting, and installing new GI Genius Accounts at enterprise level MSO/IDN headquarters, Hospitals and ASC’s.
  • Further defines the direction for new products (primarily but not limited to GI Genius), processes, standards, or operational plans based on business strategy with a significant impact on work group results. Excellence in Medtronic GI portfolio integration into GI Genius sales processes and documented sales achievement.
  • Represents organization as a primary contact for specific projects and initiatives. Ability to identify and leverage internal and external customers and vendors at various levels. May negotiate with others to reach understanding or agreement, and influence decision-making.
  • Successfully develop the sales and clinical organization in their assigned geographic territory by sharing GI Genius product expertise, skill set and sales knowledge. Success is defined by focused product quota achievement.
  • Develops solutions to complex problems, and/or makes significant improvements of processes, systems, or products independently to enhance performance of job area. Executes identified solutions.
  • Provide solution-oriented strategies to facilitate product adoption and accelerate sales growth.
  • Establish relationships with healthcare executives, physicians and KOL’s in their territory where procedures are performed or influenced.
  • Interact with physicians, hospital executives and service line administrators to close sales and drive ongoing utilization of our solution-based software technology as cleared by the U.S. FDA, as appropriately regulated
  • Possess and deliver a thorough understanding of healthcare economics specific to the customer and deliver targeted messaging to validate the value proposition of Medtronic AI platforms
  • Initiate and lead engagements with internal cross-functional leaders to accelerate and close the sales process.
  • Significant travel required – 75%
  • Understands and delivers the clinical value of Medtronic AI platforms, including published evidence, disease pathways and ground truth development of algorithms.
  • Provide clinical product demonstrations and education in accounts through individual and group interactions to increase the customers' understanding and proficiency.
  • Demonstrate disease state expertise in all areas for which the products are used.
  • Proactively understand and articulate clinical and journal articles in all relevant disease states, regardless of study outcome and Medtronic positioning.
  • Comprehensive knowledge of the utility and consistent activity in CRM, with the ability to present pipeline and forecasts
  • Consistently complete administrative responsibilities, such as expense reports, sales reports, and other business requests.
  • Perform all on-line training within assigned timelines demonstrating proficiency.
  • Awareness and adherence to Medtronic code of conduct policy.
Desired Qualifications
  • Enterprise level technical sales, with life science, healthcare, or software (SaaS, PaaS, SaMD) background strongly preferred
  • Proven consistent record of accomplishment of sales success exceedingly quarterly and yearly sales quota (President's Club or consistent top performer sales accomplishment rankings)
  • Demonstrated clinical, technical, and business excellence with GI Genius
  • Strong written and oral communication skills
  • Proficiency in O365 suite & Salesforce.com
  • Ability to establish and maintain good working relationships with all functional areas
  • Demonstrated business planning and forecasting excellence
  • Medical device/equipment sales experience.
  • Experience selling to physicians in a procedural setting.
  • Degree with emphasis in Life Sciences, Medicine, or related technical field.
  • Ability to multi-task and work independently.

Medtronic makes medical devices and therapies to treat chronic diseases, including implantables, sensors, and diabetes management tools. Its devices interact with the body to regulate or monitor functions, such as pacemakers delivering heart stimulation and neuromodulation devices sending electrical signals. The company differentiates itself through a long history of device development and a broad portfolio, expanded via acquisitions to access new technologies and markets. Its goal is to improve patient health outcomes by providing integrated medical technologies that help manage chronic conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Designation accelerates Sphere-9 VT pivotal trial.
  • Led $100M Pulnovo Medical round for heart failure therapy.
  • $20M Orchestra BioMed investment advances hypertension trial.

What critics are saying

  • ShinyHunters exfiltrates 9M records, triggers lawsuits by Q3 2026.
  • Jefferies cuts price target to $95, stock drops 10% in weeks.
  • MiniMed IPO spins out diabetes unit, dilutes revenue by 2027.

What makes Medtronic unique

  • Pioneered first wearable battery-powered pacemaker in 1957.
  • Developed Affera Sphere-9 catheter with dual-energy ablation for VT.
  • Launched Stealth AXiS AI-powered surgical navigation system.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

Yahoo Finance
Apr 10th, 2026
GE HealthCare and Medtronic launch integrated neurosurgery imaging and navigation system

Medtronic and GE HealthCare have launched a digital integration combining GE's bkActiv intraoperative ultrasound with Medtronic's Stealth AXiS surgical navigation system for cranial neurosurgery. The commercially available system provides real-time imaging during procedures, connecting Medtronic's navigation and robotics platforms with GE HealthCare's imaging technology. The integration aims to enhance clinical decision-making during complex cranial procedures through precise guidance and visualisation. It may influence hospital equipment purchasing decisions, surgeon productivity and operating room efficiency. Medtronic currently trades at $87.91, approximately 19.8% below the $109.64 analyst target range midpoint. The stock has experienced a 2.2% decline over the past 30 days. Adoption rates amongst surgeons and hospitals, alongside hospital capital spending on neurosurgery suites, will be key factors to monitor.

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Yahoo Finance
Apr 7th, 2026
Stifel cuts Medtronic price target to $95 from $105 on MiniMed IPO dilution

Stifel has lowered its price target on Medtronic (NYSE:MDT) to $95 from $105, maintaining a Hold rating. The adjustment reflects transaction-related impacts from the 9 March IPO of Medtronic's Diabetes business, now called MiniMed. MiniMed will remain a consolidated subsidiary until formal separation, expected about six months post-IPO. Stifel continues to model full Diabetes business revenue whilst adjusting for the 10% non-controlling interest sold in the IPO. Management expects IPO-related earnings per share dilution of 1-2 cents monthly until separation completes. Separately, the US Food and Drug Administration recently cleared Medtronic's Stealth AXiS surgical system for cranial and ear, nose and throat procedures, expanding beyond its earlier spine indication.

Silicon Republic
Apr 3rd, 2026
What impact might Medtronic's new lab have on Galway's medtech ecosystem?

What impact might Medtronic's new lab have on Galway's medtech ecosystem? 3 Apr 2026 From left: Ruth Callanan, Ronan Rogers and John Caulfield. Image: Andrew Downes/Xposure Ronan Rogers and Ruth Callanan discuss innovation in the west of Ireland and the evolution of Ireland's STEM careers. Ireland's medtech sector is moving beyond traditional biomedical engineering, according to Ronan Rogers, the senior R&D director for cardiac ablation solutions at Medtronic. He explained the region has built "real depth", not just in medtech, but across key areas such as pharmaceutical science, advanced analytics and digital technology. Areas that are now "increasingly converging". "That diversity of opportunity is a huge strength for Ireland," he told SiliconRepublic.com. "It allows people from different professional backgrounds to find meaningful, high-impact careers in healthcare, while helping Ireland move further up the value chain as a centre for complex, globally relevant innovation." Having recently expanded its Galway-based pharmaceutical laboratory, the Medtronic facility now serves as a west of Ireland hub for high-tech innovation and the evolving needs of the global healthcare space. Rogers is of the opinion that this is reflective of the convergence of the country's medtech divisions. Noting that the primary purpose of the lab "is to integrate pharmaceutical, engineering and analytical expertise under one roof to address the complex challenges of combination products, [that is] where a medical device and a medicine work together". "We see that convergence very clearly in this laboratory and there is a wide range of career paths in our industry, whether that's a pharmacist drawn to the faster innovation cycles and applied science of medtech, or a software developer who wants to use their skills to solve real healthcare challenges and code with a deeper sense of purpose." What opportunities exist? With the expansion comes the opportunity for students and professionals to consider a new role, either as part of Medtronic or within Galway's thriving life science and medtech spaces. "Galway offers a unique innovation ecosystem where infrastructure, academic partnerships and a significant medtech footprint all provide a strong foundation for sustaining Ireland's leadership in the life sciences sector," said Ruth Callanan, Medtronic's director of site quality. With the investment focused on significantly expanding R&D capability and technical depth within a critical space in the Irish medtech sector, Medtronic has increased lab space by almost a half and introduced analytical technologies that didn't exist there before. Callanan said: "This creates the conditions for future high-value work as programmes grow. It strengthens Galway's ability to attract and retain highly specialised talent, pharmaceutical scientists, chemical and materials engineers and it allows work that was previously outsourced internationally to be done here in Ireland. "Over time, as demand and activity scale, we do expect this capability to support additional specialist roles, phased in over the coming years. Importantly, it reinforces Ireland's position at the forefront of advanced medtech R&D and reflects a broader industry trend toward self-sufficiency in high-tech analytical testing." Step into the future. She explained the new lab will enable experts to integrate processes as the facility will be responsible for the entire life cycle of product development, from early phase R&D through to post-market oversight. She added: "The laboratory utilises advanced LCMS [liquid chromatography-mass spectrometry] and GCMS [gas chromatography-mass spectrometry] technologies, which act as 'molecular microscopes'. This allows our scientists to identify unknown compounds or impurities at extremely precise levels." According to Rogers, the new lab has a role to play in what he believes to be the reshaping of how STEM careers in Ireland are perceived and pursued, with Callanan noting this creates for students and professionals opportunities to engage with careers that bridge the gap between various scientific disciplines. "A laboratory of this size and complexity requires students and professionals with a wide range of skills and experience across multiple disciplines," she said. "Just as importantly," added Rogers, "we're sending a clear signal to pharmacists, chemists and analytical scientists that medtech offers deep, intellectually challenging career paths that go well beyond traditional manufacturing or even classical biomedical engineering." Laura Varley is the Careers editor for Silicon Republic

The Irish Post
Mar 31st, 2026
Medtronic launches new pharmaceutical lab in Galway.

Medtronic launches new pharmaceutical lab in Galway. A GLOBAL health tech leader which is headquartered in Galway has unveiled a new laboratory in the city. Medtronic has formally opened a new Pharma Laboratory and Building 6 at its location in Parkmore. Galway TD and Minister of State Seán Canney attended the launch event this month. Minister Seán Canney (centre) attended the opening of the new laboratory this month "Great to be in Parkmore to officially open the new Pharma Laboratory and Building 6 at Medtronic," he said. "This is a really significant investment for Galway and for the West - strengthening our position as a global leader in MedTech and supporting the next generation of innovation." He added: "The facility will act as a "one-stop shop" for testing and validating drug-device combination products - a fast-growing area that is improving outcomes for patients worldwide. "Medtronic has been part of Galway for over 40 years, and what's been built here is genuinely world-class. "It reflects the strength of the talent, the ecosystem, and the ambition that exists across this region. Most importantly, this is about impact - better treatments, better technologies, and better outcomes for patients. "A real vote of confidence in Galway and in Ireland." Everything from irishpost.com and the print edition is available on the Irish Post App - plus more! Download it for Android or Apple IOS devices today.

INACTIVE